| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 341.425 | 270.530 | 340.623 | 368.210 | 482.217 | 165.643 | 375.941 | 226.860 | 241.435 | 221.934 |
| Total Income - EUR | 341.943 | 271.446 | 342.643 | 370.829 | 482.988 | 174.401 | 450.532 | 229.435 | 247.516 | 228.103 |
| Total Expenses - EUR | 308.353 | 245.400 | 297.788 | 294.745 | 406.878 | 184.340 | 353.243 | 245.270 | 219.054 | 180.332 |
| Gross Profit/Loss - EUR | 33.591 | 26.046 | 44.855 | 76.083 | 76.109 | -9.940 | 97.290 | -15.836 | 28.462 | 47.771 |
| Net Profit/Loss - EUR | 26.857 | 21.343 | 40.689 | 72.377 | 71.284 | -11.467 | 93.595 | -17.864 | 26.088 | 41.238 |
| Employees | 8 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 6 | 5 |
Check the financial reports for the company - Genetyp Solutions Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.860 | 14.203 | 9.181 | 18.684 | 22.829 | 20.076 | 35.434 | 53.290 | 35.533 | 18.784 |
| Current Assets | 194.120 | 118.745 | 121.218 | 161.171 | 154.874 | 196.171 | 162.992 | 83.155 | 87.484 | 100.024 |
| Inventories | 53.041 | 59.446 | 59.839 | 67.899 | 61.590 | 55.921 | 28.402 | 28.902 | 27.298 | 33.043 |
| Receivables | 128.274 | 52.351 | 58.161 | 87.984 | 78.168 | 42.619 | 61.170 | 44.272 | 59.235 | 66.565 |
| Cash | 12.805 | 6.948 | 3.218 | 5.288 | 15.116 | 97.631 | 73.420 | 9.981 | 951 | 416 |
| Shareholders Funds | 156.766 | 68.687 | 76.414 | 106.673 | 135.963 | 45.753 | 112.799 | 26.981 | 26.618 | 41.305 |
| Social Capital | 63 | 62 | 61 | 60 | 59 | 58 | 57 | 57 | 57 | 56 |
| Debts | 56.521 | 64.292 | 53.985 | 81.664 | 52.863 | 108.830 | 85.627 | 93.206 | 85.556 | 74.383 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 70.930 | 0 | 19.241 | 14.068 | 8.902 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6290 - 6290" | |||||||||
| CAEN Financial Year |
6209
|
|||||||||
Comments - Genetyp Solutions Srl